Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States
Alimentary Pharmacology & Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 5, 2025
ABSTRACT
Objective
Primary
liver
cancer
(PLC)
is
projected
to
be
the
third
leading
cause
of
mortality
in
United
States
2040.
We
examine
burden
PLC
States,
stratified
by
sex,
state
and
aetiological
risk
factors.
Methods
Data
on
prevalence,
incidence,
death
disability–adjusted
life
years
(DALYs)
were
extracted
from
Global
Burden
Disease
Study
2021.
Changes
these
parameters
calculated
using
Joinpoint
regression
model.
Results
There
47,970
cases,
31,450
incident
24,770
deaths
576,920
DALYs
States.
The
highest
prevalence
(16,980),
incidence
(12,040),
(9840)
(213,410)
due
chronic
hepatitis
C
virus
infection.
From
2000
2021,
incidences
increased
141%,
136%.
Age–standardised
rates
(ASIRs)
(ASDRs)
per
100,000
population
for
increased,
primarily
driven
alcohol–related
disease
(ALD)
(ASIR:
annual
percent
change
[APC]:
+2.40%;
ASDR:
APC:
+2.22%)
metabolic
dysfunction–associated
steatotic
(MASLD)
+2.32%;
+2.04%).
Conclusion
has
risen
past
two
decades,
mainly
ALD
followed
MASLD.
These
findings
offer
policymakers
an
accurate
assessment
emphasise
need
targeted
factor
mitigation,
especially
regarding
alcohol
related
policy.
Language: Английский
Editorial: Lipidomics in MASLD and MetALD
Rajalakshmi Govalan,
No information about this author
Vincent Chen
No information about this author
Alimentary Pharmacology & Therapeutics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Language: Английский
Early-Onset Gastrointestinal Cancers and Metabolic Risk Factors: Global Trends From the Global Burden of Disease Study 2021
Mayo Clinic Proceedings,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
Liver and Atherosclerotic Risk of Alcohol Consumption in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Shaowen Wang,
No information about this author
C. H. Wang,
No information about this author
Yu‐Ming Cheng
No information about this author
et al.
Atherosclerosis,
Journal Year:
2025,
Volume and Issue:
403, P. 119161 - 119161
Published: March 7, 2025
Language: Английский
The Burden of Alcohol and Substance Use Disorders in Adolescents and Young Adults
Drug and Alcohol Dependence,
Journal Year:
2024,
Volume and Issue:
266, P. 112495 - 112495
Published: Nov. 14, 2024
Language: Английский
The steatotic liver disease burden paradox: unravelling the key role of alcohol
Nature Reviews Gastroenterology & Hepatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 5, 2024
Language: Английский
Alcohol-related liver and extrahepatic malignancies: burden of disease and socioeconomic disparities in 2019
European Journal of Gastroenterology & Hepatology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
Background
Alcohol
is
linked
to
various
cancers.
While
many
studies
have
focused
on
developed
countries,
the
burden
of
alcohol-related
cancers
in
developing
countries
remains
underexplored.
Methods
We
analyzed
data
from
Global
Burden
Disease
Study
(2000–2019)
assess
mortality
and
disability-adjusted
life
years
(DALYs)
low
low-to-middle
sociodemographic
index
(SDI)
countries.
Results
In
2019,
there
were
494
730
cancer.
Low
low-middle
SDI
contributed
over
15%
global
Among
multiple
types
cancer,
other
pharyngeal
these
accounted
for
30%
Primary
liver
cancer
exhibited
highest
(
n
=
16
090)
deaths
DALYs
rates
decreased
globally
between
2000
related
increased
with
a
rise
all
cancers,
except
primary
The
most
rapidly
growing
(+2.25%),
whereas
colorectal
evidenced
increase
(+2.76%).
Conclusion
has
risen
SDI,
especially
Policymakers
should
focus
improving
policies
as
well
screening
availability
tackle
associated
resource-constrained
However,
difficulty
isolating
impact
alcohol
due
limited
confounders
necessitates
caution
interpreting
findings.
Language: Английский
Increased mortality from alcohol use disorder, alcohol‐associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021
Alcohol Clinical and Experimental Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 19, 2024
Abstract
Background
To
investigate
the
trends
in
alcohol‐associated
liver
disease
(ALD),
cancer
from
alcohol,
and
alcohol
use
disorder
(AUD)
burden
among
older
adults
United
States
(US).
Methods
We
gathered
ALD,
AUD
prevalence,
mortality,
age‐standardized
rates
(ASRs)
Global
Burden
of
Disease
(GBD)
Study
2021
between
2010
2021.
estimated
annual
percent
change
(APC)
with
confidence
intervals
(CIs)
for
(>70
years)
States.
The
findings
were
contrasted
global
estimates
categorized
by
sex
state.
Results
In
2021,
there
approximately
512,340
cases
AUD,
56,990
4490
primary
contrast
to
declining
ASRs
prevalence
mortality
burden,
these
parameters
increased
From
2000
(APC:
0.54%,
95%
CI
0.43%
0.65%),
ALD
(APC
+
0.22%
0.86%),
2.93%,
2.76%
3.11%)
increased.
Forty
states
exhibited
a
rise
adults.
Conclusion
Our
highlighted
Sates,
contrasting
decline
trends.
Public
health
strategies
on
which
targets
adults,
are
urgently
needed.
Language: Английский